...before next year's marathon. We'll get another chance to show visitors how welcoming we can be. Lance Armstrong's participation in the Amgen Tour of California in February (the 18th and 19th) is sure to draw lots of cycling enthusiasts to the Valley host cities...

...Pharmaceuticals - Takeda Pharmaceuticals - Sanofi-Aventis - Pfizer - Roche - Merck - Eli Lilly - Baxter Healthcare - Amgen - Vertex Pharmaceuticals - Theratechnologies - TAP - Stiefel - Shire - PDL - King Pharmaceuticals - Indegene...

... - Advanced Technology Materials - Aerospace Corp - Affymetrix - Agilent - Akzona - Alcatel-Lucent - AMD - Amgen - Angstrom - Applied Materials - AstraZeneca - AT&T - BASF - Battelle - Bayer - BioForce Nanosciences - Biomaterials...

...Co., Johnson & Johnson, GlaxoSmithKline Plc., Novartis, Sanofi-Aventis Group, AstraZeneca Plc, Merck & Co., Genentech Inc., Amgen Inc., Abbott Laboratories, Wyeth, Eli Lilly and Co., Bristol-Myers Squibb Co., and Bayer 21 Table 18: Leading Global Pharmaceutical...

...it burning through it? This, of course, is a national story that will reverberate locally. Profitable industry powerhouses like Amgen and Genentech aren’t in trouble, but about half of the 248 unprofitable biotechs that are publicly traded have less than a...

...published new guidelines for treating anemia associated with chronic kidney disease. The guidelines were underwritten with support from Amgen, which markets a drug for anemia, and some members of the panel that developed the guidelines had financial ties to...

...of 4,802 percent. The Defendants in the newest cases are: Ivax Pharmaceuticals, Bayer Pharmaceutical Corporation, Eli Lilly, AMGEN/IMMUNEX Corporation, Fujisawa Healthcare, Inc., Sanofi-Aventis, Inc., Shire Pharmaceutical, Genzyme, Otsuka America, Sepracor,...

...FDA advisory committee meeting, but my guess is that these reports won't hamper sales much. This is much more like TNF inhibitors -- Amgen (Nasdaq: AMGN) and Wyeth's Enbrel, Abbott Labs' (NYSE: ABT) Humira, and Johnson & Johnson's (NYSE: JNJ) Remicade -- having...

...recruit people here? A. We’re getting people from San Diego, where biotech is in a down cycle, and from Thousand Oaks, where Amgen has been laying off. Pfizer announced they’re closing an ophthalmic R&D center in San Diego. So you can say other people’s misfortune...

...and support operations through its North American, U.K. and European offices. Brainware customers include Airbus, Alcon, Alltel, Amgen, Anadarko, BB&T, British American Tobacco, ConocoPhillips, Halliburton, Her Majesty's Prison Service, JohnsonDiversey, Kimberly-Clark,...